Comparison Chart BioCryst Pharmaceuticals, Inc.

Stocks

BCRX

US09058V1035

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 16:00:00 2026-06-22 EDT			5-day change	1st Jan Change
9.140 ^USD	+1.67%		+0.88%	+17.18%

06-12	BioCryst Pharmaceuticals' New Clinical Data Demonstrated Reduced Hereditary Angioedema Attacks With Orladeyo Treatment	MT
06-12	BioCryst Pharmaceuticals Presents New Clinical Data and Real-World Evidence for HAE Portfolio at the European Academy of Allergy and Clinical Immunology Annual Meeting	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	BIOCRYST PHARMACEUTICALS, INC.	Bio Therapeutic Drugs	+1.67%	+0.88%	+17.18%	-9.50%	-45.11%	2.32B